Facebook
X
LinkedIn
ForwardInterpreting Genetic Test Results
Part of an ongoing CE-accredited series that aims to help providers navigate the complexities of genetic testing through discussion with genetic counselors. In this session, panelists will share best practices from their experiences within their institutions, and help you navigate the process & challenges that arise when interpreting genetic testing results.
Target Audience
This activity is designed for an audience of nurses, nurse practitioners, pharmacists, physicians, physician associates and social workers.
Learning Objectives
- Recognize the different types of genetic test results.
- Identify and navigate nuances associated with specific disease states or challenging report types.
- Leverage tools and resources discussed to streamline communication across stakeholders.
Commercial Support
There is no commercial support for this activity.
DISCLOSURES | ||
Name | Relationship | Commercial Interest |
Jordan Bontrager, MS, CGC | N/A | Nothing to disclose |
Chelsea Chambers, MS, CGC | Speaker | Biogen |
Christina Dailey, MS, CGC | N/A | Nothing to disclose |
Jacie Ihinger, MS, CGC | N/A | Nothing to disclose |
Bernadette Makar, MSN, APRN-BC, NP-C (planner/reviewer) | N/A | Nothing to disclose |
Dorothy Duffy, RPh (planner/reviewer) | N/A | Nothing to disclose |
Broc Pollinger, MSW, LSW, OSW-C, (planner/reviewer) | N/A | Nothing to disclose |
AKH Inc Staff and Planners | N/A | Nothing to disclose |
MDA Staff and Planners | N/A | Nothing to disclose |
All of the relevant financial relationships listed for these individuals have been mitigated. | ||
It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with ineligible companies whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are mitigated by AKH prior to accreditation of the activity. AKH planners and reviewers have no relevant financial relationships to disclose.
Disclosure of Unlabeled Use and Investigational Product
This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participants misunderstanding of the content. If you would like to opt out from future communications from AKH please send an email to [email protected] with your information with "Opt Out" in the subject line.
In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare and MDA. AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
This activity was planned by and for the healthcare team, and learners will receive 1.5 Interprofessional Continuing Education (IPCE) credit for learning and change.
Physicians
AKH Inc., Advancing Knowledge in Healthcare designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Pharmacists
AKH Inc., Advancing Knowledge in Healthcare designates this continuing education activity for 1.5 contact hours.
Nursing
Credit being awarded: 1.5 ANCC contact hours
Physician Associates
AKH Inc., Advancing Knowledge in Healthcare has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.5 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
Nurse Practitioners
This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners (AANP) through the joint providership of AKH Inc., Advancing Knowledge in Healthcare and MDA. AKH Inc., Advancing Knowledge in Healthcare is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 030803. This activity is pending approval of up to 1.5 continuing education credit
Social Workers
As a Jointly Accredited Organization, AKH Inc., Advancing Knowledge in Healthcare is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. AKH Inc. Advancing Knowledge in Healthcare maintains responsibility for this course. Social workers completing this course receive 1.5 continuing education credits.
Available Credit
- 1.50 AANP
- 0.00 AANP Pharmacology Contact Hours
- 1.50 AAPA Category 1 CME
- 1.50 ACPE Pharmacist
- 1.50 AMA PRA Category 1 Credit™
- 1.50 ANCC
- 1.50 ASWB
- 1.50 Attendance